Amanote Research

Amanote Research

    RegisterSign In

Evaluating Risks for Vigabatrin Treatment

Epilepsy Currents - United States
doi 10.1111/j.1535-7511.2009.01315.x
Full Text
Open PDF
Abstract

Available in full text

Categories
Neurology
Date

September 1, 2009

Authors
Gregory L. Krauss
Publisher

SAGE Publications


Related search

Vigabatrin.

BMJ
1990English

Vigabatrin

Neurotherapeutics
NeurologyPharmacology
2007English

Research on Model for Evaluating Risks of Venture Capital Projects

Journal of Risk Analysis and Crisis Response
2011English

NRC Committee Evaluating Sewage Sludge Health Risks

Environmental Science & Technology
MedicineEnvironmental ChemistryChemistry
2001English

Approaches to Evaluating Reproductive Hazards and Risks

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1993English

Water Treatment for Reducing Risks in Albanian Conditions

South East European University Review
2011English

Methodology for Evaluating the Risks of Activities Termination, Related With Ineffective Company Management

Statistics of Ukraine
2017English

FDA Bars Own Expert From Evaluating Risks of Painkillers

BMJ
2004English

Second Moment Method for Evaluating Human Health Risks From Groundwater Contaminated by Trichloroethylene

Environmental Health Perspectives
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational Health
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy